Clinical Trial

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

Study acronym: PIVATAL
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
To investigate the effect of VTA ablation at the time of LVAD implant to see if it can reduce the incidence of VTA after surgery
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-04-30 -> 2027-04-30 2026-07-15
Trial Details
NCT Number NCT05034432
Lead Sponsor University of Rochester
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Arrythmia, Cardiomyopathies
Enrollment 100 participants
Start Date 2022-05-27
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-14